Skip to main content
. 2012 May 18;7(5):e37244. doi: 10.1371/journal.pone.0037244

Figure 6. LCTA-949 prevents antibody-dependent enhancement of DENV infection.

Figure 6

P388D1 cells were infected with DENV pre-opsonized with anti-E mAb DV2-104 at an MOI of 10 in presence of increasing concentrations of LCTA-949. Anti-E DV2-104 was used at a concentration of 400 ng/ml. The percentage of inhibition of infection after LCTA-949 treatment was calculated with respect to the positive control of untreated opsonized virus. Data are expressed as the means ± SD from two separate experiments, each of which was carried out in duplicate.